Cargando…

Highlights in ASCVD Primary Prevention for 2021

This review examines key studies published in 2021 that are related to primary prevention of atherosclerotic cardiovascular disease (ASCVD). Major randomized clinical trials (RCTs) concerning traditional risk factors or ASCVD events, meta‐analyses, and key observational studies related to primary pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polonsky, Tamar S., Khera, Amit, Miedema, Michael D., Schocken, Douglas D., Wilson, Peter W. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333377/ https://www.ncbi.nlm.nih.gov/pubmed/35785971 http://dx.doi.org/10.1161/JAHA.122.025973

Ejemplares similares

Exploring Opportunities for Primary Prevention of Unprovoked Venous Thromboembolism: Ready for Prime Time?
por: Folsom, Aaron R., et al.
Publicado: (2020)

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions
por: Khera, Rohan, et al.
Publicado: (2020)

What Is the Best Mix of Population‐Wide and High‐Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
por: Feigin, Valery L., et al.
Publicado: (2020)

Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated
por: Sniderman, Allan D., et al.
Publicado: (2018)

Time to Shock the System: Moving Beyond the Current Paradigm for Primary Prevention Implantable Cardioverter‐Defibrillator Use
por: Merchant, Faisal M., et al.
Publicado: (2020)

Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention
por: Kohli, Payal, et al.
Publicado: (2014)

Health Literacy is Essential to ASCVD Prevention in Youth
por: Mann, Harnoor K., et al.
Publicado: (2023)

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
por: Wilkinson, Michael J., et al.
Publicado: (2023)

Echocardiographic Imaging for Transcatheter Tricuspid Edge‐to‐Edge Repair
por: Ro, Richard, et al.
Publicado: (2020)

Clinical Potential of Beat‐to‐Beat Diastolic Interval Control in Preventing Cardiac Arrhythmias
por: Kulkarni, Kanchan, et al.
Publicado: (2021)

Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Collado, Fareed Moses S., et al.
Publicado: (2021)

Contemporary Concise Review 2021: Interstitial lung disease
por: McCarthy, Cormac, et al.
Publicado: (2022)

Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review
por: Kotadia, Irum D., et al.
Publicado: (2021)

Physical Activity in the Prevention and Treatment of Coronary Artery Disease
por: Winzer, Ephraim Bernhard, et al.
Publicado: (2018)

Cardiac Alternans: Mechanisms and Clinical Utility in Arrhythmia Prevention
por: Kulkarni, Kanchan, et al.
Publicado: (2019)

Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders
por: Collado, Fareed Moses S., et al.
Publicado: (2018)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
por: Borne, Ryan T., et al.
Publicado: (2017)

Diagnostic Approach for Suspected Acute Myocarditis: Considerations for Standardization and Broadening Clinical Spectrum
por: Martens, Pieter, et al.
Publicado: (2023)

COVID‐19, Social Determinants of Health, and Opportunities for Preventing Cardiovascular Disease: A Conceptual Framework
por: Russo, Rienna G., et al.
Publicado: (2021)

Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)
por: Parums, Dinah V.
Publicado: (2021)

Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group
por: Gooding, Holly C., et al.
Publicado: (2020)

Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches?
por: Lip, Gregory Y. H., et al.
Publicado: (2014)

An Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes
por: Cove, Christina L., et al.
Publicado: (2013)

Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk
por: Rikhi, Rishi, et al.
Publicado: (2022)

Artificial Intelligence: Practical Primer for Clinical Research in Cardiovascular Disease
por: Kagiyama, Nobuyuki, et al.
Publicado: (2019)

A Pilot Study of Home Treatment of Deep Vein Thrombosis With Subcutaneous Once-Daily Enoxaparin Plus Warfarin
por: Bishop, Beverly, et al.
Publicado: (2006)

Association Between Work‐Related Stress and Coronary Heart Disease: A Review of Prospective Studies Through the Job Strain, Effort‐Reward Balance, and Organizational Justice Models
por: Sara, Jaskanwal D., et al.
Publicado: (2018)

Role of Volume Redistribution in the Congestion of Heart Failure
por: Fudim, Marat, et al.
Publicado: (2017)

Summary Report of the Arthritis Foundation and the American Orthopaedic Foot & Ankle Society’s Symposium on Targets for Osteoarthritis Research: Part 1: Epidemiology, Pathophysiology, and Current Imaging Approaches
por: Kim, Jason S., et al.
Publicado: (2022)

Summary Report of the Arthritis Foundation and the American Orthopaedic Foot & Ankle Society’s Symposium on Targets for Osteoarthritis Research: Part 2: Treatment Options
por: Kim, Jason S., et al.
Publicado: (2022)

Impact on Drug Costs and Utilization of a Clinical Pharmacist in a Multisite Primary Care Medical Group
por: Walker, Scot, et al.
Publicado: (2004)

Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier
por: Nollet, Edgar E., et al.
Publicado: (2020)

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
por: Robinson, Jennifer G., et al.
Publicado: (2018)

The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
por: Greene, Stephen J., et al.
Publicado: (2013)

Defining a Mobile Health Roadmap for Cardiovascular Health and Disease
por: Eapen, Zubin J., et al.
Publicado: (2016)

Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and Outcomes
por: Gaudino, Mario, et al.
Publicado: (2019)

Off‐Pump Coronary Artery Bypass Grafting: 30 Years of Debate
por: Gaudino, Mario, et al.
Publicado: (2018)

Harmonizing the Paradigm With the Data in Stable Coronary Artery Disease: A Review and Viewpoint
por: Mitchell, Joshua D., et al.
Publicado: (2017)

Expanding statin use for prevention of ASCVD in Indians: Reasoned and simplified proposals
por: Enas, Enas A., et al.
Publicado: (2020)

Left Ventricular Assist Devices: A Primer For the General Cardiologist
por: Chaudhry, Sunit‐Preet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r3vnh0m55at3boe69vnaa0kif0